Myriad Genetics (MYGN) Change in Cash (2016 - 2025)
Myriad Genetics (MYGN) has disclosed Change in Cash for 17 consecutive years, with -$3.5 million as the latest value for Q4 2025.
- Quarterly Change in Cash fell 266.67% to -$3.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $39.4 million through Dec 2025, up 235.86% year-over-year, with the annual reading at $39.4 million for FY2025, 235.86% up from the prior year.
- Change in Cash for Q4 2025 was -$3.5 million at Myriad Genetics, down from $71.1 million in the prior quarter.
- The five-year high for Change in Cash was $176.8 million in Q3 2021, with the low at -$93.2 million in Q1 2022.
- Average Change in Cash over 5 years is $1.7 million, with a median of -$4.0 million recorded in 2024.
- The sharpest move saw Change in Cash tumbled 969.7% in 2024, then surged 726.74% in 2025.
- Over 5 years, Change in Cash stood at -$36.4 million in 2021, then decreased by 21.7% to -$44.3 million in 2022, then skyrocketed by 226.19% to $55.9 million in 2023, then plummeted by 96.24% to $2.1 million in 2024, then plummeted by 266.67% to -$3.5 million in 2025.
- According to Business Quant data, Change in Cash over the past three periods came in at -$3.5 million, $71.1 million, and -$17.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.